One molecule's journey from discovery to market
Monday, June 22, 2020 - 00:20
in Health & Medicine
With the help of outsourcing partners, the small biotech firm Nabriva brought lefamulin to patients by itself. Now it needs to make a profit in the tough-to-crack antibiotic business